Skip to content

Gastrointestinal Dysfunction in Aortic Surgery Patients

Assessment of Gastrointestinal Dysfunction Through GIDS Scale and Intestinal Damage Biomarkers in Critically Ill Patients Undergoing Aortic Surgery and Its Association With Clinical Outcomes.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06514170
Enrollment
114
Registered
2024-07-23
Start date
2024-07-23
Completion date
2026-06-30
Last updated
2024-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Aortic Diseases, Enteral Feeding Intolerance, Gastrointestinal Dysfunction, Surgical Complication

Keywords

Gastrointestinal dysfunction, Aortic diseases, Aorta surgery

Brief summary

The goal of this observational study is to determine the association of gastrointestinal dysfunction through the Gastrointestinal Dysfunction Scale (GIDS) tool and serum concentrations of citrulline and Intestinal fatty-acid binding protein (I-FABP) with primary \[calories received, protein received, parenteral nutrition requirement and 28-day mortality in the intensive care unit (ICU)\] and secondary (development of pneumonia, surgical and cardiovascular complications in the ICU, length of hospital and ICU stay, duration of mechanical ventilation) clinical outcomes in critically ill patients undergoing aortic surgery.

Detailed description

The treatment of choice for various cardiovascular diseases often involves cardiac surgery, including aortic surgery, which is performed to correct conditions related to this major vessel, such as aneurysms, stenosis, aortic dissections, as well as issues affecting the aortic valve. With the increasing prevalence of non-communicable chronic diseases, a 46% increase in demand for cardiac surgeries is projected by 2025. The post-surgical period, commonly in the intensive care unit (ICU), increases the risk of complications, especially in patients with pre-existing risk factors. In this regard, gastrointestinal (GI) dysfunction affects up to 63% of patients, being associated with complications and a mortality rate of 55% to 60%. Early detection of GI dysfunction allows for the implementation of management strategies. Additionally, the administration of appropriate nutritional therapy is essential for recovery, and GI dysfunction may limit nutrient absorption. Inadequate caloric intake has been linked to increased morbidity and mortality. Tools such as GIDS (Gastrointestinal Dysfunction Scale) and biomarkers like citrulline and I-FABP enable early evaluation of GI function, advancing monitoring and management. Identifying changes before serious complications arise allows for early and personalized interventions. Early detection not only prevents complications and improves quality of life but may also reduce mortality. This research project aims to address these gaps by early assessing GI dysfunction in post-aortic surgery patients. Utilizing the GIDS tool and biomarkers such as citrulline and I-FABP, the goal is to identify GI dysfunction early and its impact on nutrition administration.

Interventions

OTHERNo intervention

No intervention

Sponsors

Instituto Nacional de Enfermedades Respiratorias
CollaboratorOTHER_GOV
National Polytechnic Institute, Mexico
CollaboratorOTHER
Instituto Nacional de Cardiologia Ignacio Chavez
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older. * Patients after surgical interventions (elective or urgency) on the aorta with cardiopulmonary bypass. * Invasive mechanical ventilation expected to be required more than 48 hours. * Signed informed consent.

Exclusion criteria

* Patients under mechanical ventilation with pre-existing gastrointestinal issues. * Diagnosis of adult congenital heart disease. * Ongoing pregnancy or lactation period. * Simultaneous participation in another clinical study involving experimental therapy. * Presence of chronic intestinal disease. * Previous gastrointestinal conditions detected during nutritional screening.

Design outcomes

Primary

MeasureTime frameDescription
Calories delivered daily enterally and/or parenterallyDay 0 to day 7Percentage representation of prescribed calories delivered daily via enteral and/or parenteral routes.
Protein delivered daily enterally and/or parenterallyDay 0 to day 7Daily administration of protein (in grams) through enteral and/or parenteral routes.

Secondary

MeasureTime frameDescription
ICU readmission rate90 daysOccurrences of patients being readmitted to the ICU from within the hospital.
ICU length of stay90 daysDuration of time (days) in the ICU
Duration of mechanical ventilation90 daysLength of time (days) on mechanical ventilation (including still on mechanical ventilation at time of discharge)
Incidence rate of hospital-acquired infections7 daysInfections acquired in the hospital consist of ventilator-associated pneumonia, bloodstream infections, and infections related to urinary catheters
Parenteral nutrition requirementDay 0 to day 7Parenteral nutrition requirement
28-day mortality in the ICU28 daysIs the patient alive or deceased 28 days post admission.
Hospital length of stay90 daysDuration of time (days) in the hospital
Percentage of repeated operations90 daysThis outcome measures the percentage of patients who undergo one or more additional surgical operations related to the same condition after the initial surgery. The percentage is calculated by dividing the number of patients who require a repeat operation by the total number of patients who underwent the initial operation, multiplied by 100 to get the percentage.

Countries

Mexico

Contacts

Primary ContactGustavo Rojas Velasco, MD
gustavorojas08@gmail.com+52 55 55732911
Backup ContactJacob J Cruz Sánchez, MSc.
jacob.cruz@cardiologia.org.mx+52 5512439841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026